Response to Comments: MolDX: Biomarkers in Cardiovascular Risk Assessment (L36523)

This article is a response to public comments on the draft LCD 'MolDX: Biomarkers in Cardiovascular Risk Assessment (L36523)' and does not establish or modify specific coverage criteria. It contains no actionable indications, limitations, documentation requirements, or frequency limits; refer to the final LCD L36523 or associated MolDx policy for definitive coverage rules.